Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/06/2003CA2106955C Product and method for improving keratinocyte adhesion to the dermis
05/06/2003CA2094144C Methods and applications for efficient genetic suppressor elements
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
05/02/2003EP1306437A2 Delta opioid receptor genes
05/02/2003EP1306435A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
05/02/2003EP1306434A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
05/02/2003EP1306432A1 Human ii type 5 alpha-reductase promoter gene and use thereof
05/02/2003EP1306427A1 Method of proliferating natural killer cells
05/02/2003EP1306426A1 In vitro micro-organs, and uses related thereto
05/02/2003EP1306091A2 Stimulation of beta cell proliferation
05/02/2003EP1306005A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide
05/02/2003EP1305636A2 Screening method
05/02/2003EP1305634A2 Fluorescence assay for gamma-secretase activity and inhibitors
05/02/2003EP1305630A1 A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound
05/02/2003EP1305627A2 Protein fragment complementation assay based on beta-lactamase
05/02/2003EP1305438A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s)
05/02/2003EP1305437A2 Expression of biologically active polypeptides in duckweed
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305432A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
05/02/2003EP1305431A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
05/02/2003EP1305430A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
05/02/2003EP1305429A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305418A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
05/02/2003EP1305417A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
05/02/2003EP1305416A2 Identification of a novel glutamine transporter
05/02/2003EP1305415A1 Protein inhibitor of apoptosis proteins
05/02/2003EP1305414A2 Modified cea and uses thereof
05/02/2003EP1305412A2 Anthozoa derived chromo/fluoroproteins and methods for using the same
05/02/2003EP1305411A1 Method of producing functional protein domains
05/02/2003EP1305410A2 Insulin producing cell-line obtained by electrofusion
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305405A2 Methods of controlling gene expression and gene silencing
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305403A2 Dna element promoter of transcription activity, active in human cells and general method for adjusting the activity thereof
05/02/2003EP1305402A1 Lipo-viro-particle complexes, preparation method and uses
05/02/2003EP1305401A2 Pluripotent embryonic stem (es) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animals
05/02/2003EP1305400A2 Adult human dental pulp stem cells in vitro and in vivo
05/02/2003EP1305343A2 Peptides presented by cells
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305341A1 Dog melanin-concentrating hormone receptor
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP1305336A2 Therapeutic anti-melanoma compounds
05/02/2003EP1305335A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305331A1 Motor proteins and methods for their use
05/02/2003EP1305041A1 Medicament for the immunotherapy of malignant tumours
05/02/2003EP1304921A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1304920A2 Transgenic mice containing targeted gene disruptions
05/02/2003EP1151079A4 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use
05/02/2003EP1036167B1 Nuclear targeting by means of streptococcal protein h
05/02/2003EP0986396A4 Prion protein modulator factor (ppmf) and prion resistant animals
05/02/2003EP0983366B1 Dna encoding an arthropod chitin synthase
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0879294B1 Transduced human hematopoietic stem cells
05/02/2003EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
05/02/2003EP0808141B1 Method and apparatus for sodding microvessel cells onto a synthetic vascular graft
05/02/2003EP0730653B1 Arabinoxylan degrading enzymes
05/02/2003EP0714435B1 Pro-urokinase mutants
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/02/2003EP0653062B1 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations
05/02/2003EP0603216B1 Biocidal proteins
05/02/2003EP0592521B1 Marrow-derived human mesenchymal stem cells and monoclonal antibodies specific for said cells
05/01/2003WO2003036267A2 Filtration system and method for obtaining a cytology layer
05/01/2003WO2003036261A2 Drug development by rapid neuroimaging of neural cells
05/01/2003WO2003035888A1 Cell separation matrix
05/01/2003WO2003035887A1 Selection of cells expressing heteromeric polypeptides
05/01/2003WO2003035884A2 Transient immortalization
05/01/2003WO2003035879A2 Promoters to control cell differentiation
05/01/2003WO2003035878A2 Lipase variants
05/01/2003WO2003035866A1 Method of evaluating and identifying biologically functional molecule using marker gene
05/01/2003WO2003035861A2 Thrombin-cleavable chimeric proteins
05/01/2003WO2003035855A1 Differentiation of whole bone marrow
05/01/2003WO2003035854A1 Skeletal cell model to screen anti-diabetic compounds
05/01/2003WO2003035853A1 Pig mast cell cultures and uses thereof
05/01/2003WO2003035852A1 Mixture used to differentiate stem cells or neuronal progenitor cells in neuronal cells
05/01/2003WO2003035851A1 In vitro micro-organs, and uses related thereto
05/01/2003WO2003035850A1 Cell transfer substrate
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035845A2 Salvador tumor suppressor gene
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035838A2 Stem cells that transform to beating cardiomyocytes
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035834A2 Compositions and methods for making mutations in cell lines and animals
05/01/2003WO2003035828A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli
05/01/2003WO2003035696A2 Humanized antibodies against icam-1, their production and uses
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035685A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035576A1 Porous article of sintered calcium phosphate, process for producing the same and artificial bone and histomorphological scaffold using the same
05/01/2003WO2003035477A1 Specimen vial sealing apparatus and method
05/01/2003WO2003035126A1 Process for producing biological material, drug, food, medical instrument, cell culture instrument and tissue-inducible material
05/01/2003WO2003035104A2 Compositions and methods for selected tumor treatment
1 ... 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 ... 1827